PRESS RELEASE published on 09/26/2025 at 07:00, 1 year ago OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise Innovation Partnership Oncology Collaboration Immunotherapy
PRESS RELEASE published on 09/26/2025 at 06:30, 1 year ago Change in the Chairmanship of the Board of Directors Change in the Chairmanship of the Board of Directors at Siegfried AG as Dr. Andreas Casutt steps down, proposing Dr. Beat Walti as the new Chairman. Siegfried Holding AG continues its successful growth journey Board Of Directors Chairmanship Siegfried AG Dr. Andreas Casutt Dr. Beat Walti
PRESS RELEASE published on 09/26/2025 at 06:12, 1 year ago Ad hoc-annoucement pursuant to Art. 53 LR Adval Tech Management AG releases ad hoc announcement pursuant to Art. 53 LR. For more information, visit www.advaltech.com Ad Hoc Announcement SIX Swiss Exchange EQS News Adval Tech Management AG Art. 53 LR
PRESS RELEASE published on 09/26/2025 at 05:15, 1 year ago NioCorp Announces Commencement of Proposed Public Offering of Common Shares NioCorp commences public offering in the United States via Maxim Group LLC for its Elk Creek Project, aiming to raise capital for construction and operations Elk Creek Project NioCorp Maxim Group LLC Public Offering Capital Raising
PRESS RELEASE published on 09/26/2025 at 02:01, 1 year ago Wellgistics Health Announces Pricing of $5 Million Public Offering Wellgistics Health, Inc. (NASDAQ: WGRX) announces pricing of public offering of 7,142,862 shares of common stock at $0.70 per share. Gross proceeds expected to be $5 million. Offering by H.C. Wainwright & Co Public Offering H.C. Wainwright & Co. Pharmaceutical Distribution Wellgistics Health WGRX
PRESS RELEASE published on 09/25/2025 at 23:30, 1 year ago EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States EssilorLuxottica's Essilor Stellest lens, the first FDA market authorized spectacle lens in the U.S., clinically proven to slow myopia progression in children, with 71% effectiveness over 2 years Clinical Data EssilorLuxottica FDA Market Authorization Spectacle Lens Myopia Progression
PRESS RELEASE published on 09/25/2025 at 23:15, 1 year ago Northern Dynasty: Fourth Tranche of $12 million Royalty Investment Received, Update on Government Discussions and Court Filings Northern Dynasty Minerals Ltd. announces receipt of $12 million payment as the fourth tranche of investment under the royalty agreement, maintaining a strong treasury position for project development Northern Dynasty Minerals Ltd. Project Development Royalty Agreement $12 Million Payment Treasury Position
PRESS RELEASE published on 09/25/2025 at 22:15, 1 year ago Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report Aelis Farma announces availability of 2025 half-year financial report. Company specializes in CB1 receptor treatments for brain and peripheral diseases Financial Report Aelis Farma CB1 Receptor Brain Diseases Peripheral Diseases
PRESS RELEASE published on 09/25/2025 at 22:15, 1 year ago SMX and CETI Launch an Industrial Validation Program to Drive Circular-Economy and Traceability in Textiles & Fabrics SMX (Security Matters) PLC and CETI collaborate to bring molecular traceability to European textile and fashion industry, aiming for circular economy and sustainable practices Circular Economy Traceability SMX CETI European Textile
PRESS RELEASE published on 09/25/2025 at 20:30, 1 year ago ADM Toronto Keynotes Highlight Canada's Manufacturing Landscape ADM Toronto 2025 features top speakers discussing critical challenges and opportunities in Canada's manufacturing sector. Event covers sectors like packaging, automation, and EV technology Manufacturing Challenges Opportunities ADM Toronto 2025 Speakers
Published on 10/07/2026 at 01:45, 3 hours 52 minutes ago Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 4 hours 7 minutes ago ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 4 hours 32 minutes ago Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 5 hours 52 minutes ago Gamma Resources Closes $1,750,000 Private Placement
Published on 10/06/2026 at 23:32, 6 hours 5 minutes ago Battery X Metals Announces Closing of First Tranche of Private Placement Financing
Published on 10/06/2026 at 19:05, 10 hours 31 minutes ago Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 11 hours 6 minutes ago Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:00, 11 hours 37 minutes ago ARVERNE GROUP: Total number of shares and voting rights in the share capital as of September 30, 2026
Published on 10/06/2026 at 17:45, 11 hours 51 minutes ago EQS-Adhoc: Airbus SE: Airbus reports share buyback transactions 28 Sept. to 02 Oct. 2026
Published on 10/06/2026 at 19:15, 10 hours 22 minutes ago Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 18:39, 10 hours 57 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 11 hours 22 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026
Published on 10/06/2026 at 18:00, 11 hours 37 minutes ago Information concerning the total number of voting rights and shares in the share capital as of October 2, 2026
Published on 10/06/2026 at 17:45, 11 hours 52 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 Septembre 2026